GlassScriptPhysician profile
Carmel Joseph
NPI 1245286681
$42,835.65
in general payments reported to CMS, 2019-2025
59 companies · $3,783 in 2025
The $3,783 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,538 · 2020: $7,079 · 2021: $12K · 2022: $8,016 · 2023: $4,974 · 2024: $4,033 · 2025: $3,783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250 · Travel and Lodging: $955 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,257.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
| Travel and Lodging | $954.53 |
| Education | $328.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $19,342.32 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Intuitive Surgical, INC. | $4,524.84 | 2020-2025 | Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $3,000.62 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Actelion Pharmaceuticals US, INC. | $2,010.71 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Jazz Pharmaceuticals INC. | $1,750.28 | 2019-2025 | |
| Harmony Biosciences LLC | $1,320.64 | 2020-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,102.93 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Mallinckrodt Hospital Products INC. | $1,070.80 | 2020-2025 | Acthar |
| Medtronic, INC. | $990.26 | 2024 | Illumisite |
| Regeneron Healthcare Solutions, INC. | $641.34 | 2019-2025 | Dupixent |
| Ethicon INC. | $568.60 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $565.71 | 2019-2024 | |
| Insmed, INC. | $539.08 | 2019-2025 | Arikayce, Brinsupri |
| Merck Sharp & Dohme LLC | $508.48 | 2019-2025 | Keytruda, Winrevair |
| Axsome Therapeutics, INC. | $462.23 | 2023-2025 | Sunosi |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $461.87 | 2019-2024 | Yupelri |
| Ani Pharmaceuticals, INC. | $401.94 | 2023-2025 | Purified Cortrophin Gel |
| Grifols USA, LLC | $361.61 | 2019-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $352.72 | 2021-2024 | Tyvaso, Orenitram |
| Inari Medical, INC. | $275.84 | 2021-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $224.08 | 2023-2025 | Lumryz |
| Galvanize Therapeutics, INC | $179.82 | 2024 | Aliya System |
| Electromed, INC. | $170.48 | 2019-2025 | Smartvest |
| Sunovion Pharmaceuticals INC. | $164.42 | 2019-2020 | |
| Inspire Medical Systems, INC. | $153.41 | 2023-2025 | Inspire |
| Genzyme Corporation | $138.89 | 2021-2025 | |
| Baxter Healthcare | $115.62 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Noah Medical Corporation | $107.08 | 2024 | Galaxy |
| Optinose US, INC. | $101.21 | 2019-2020 | |
| Amgen INC. | $97.20 | 2021-2022 | |
| Lilly USA, LLC | $87.84 | 2025 | Zepbound |
| Philips North America LLC | $76.51 | 2019-2025 | Vest Therapy Und |
| Verona Pharma, INC. | $76.33 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $75.69 | 2024-2025 | Glassia |
| Kaleo, INC. | $65.67 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $57.48 | 2025 | |
| Viatris Specialty LLC | $57.46 | 2025 | Yupelri |
| Tetraphase Pharmaceuticals, INC. | $55.36 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $54.28 | 2023 | Opsumit |
| Resmed Corp | $52.38 | 2024-2025 | |
| Eisai INC. | $50.70 | 2020-2021 | |
| Vifor Pharma, INC. | $48.63 | 2024-2025 | Zemaira |
| Advanced Respiratory, INC | $46.09 | 2020 | |
| Nabriva Therapeutics, Plc | $41.88 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $39.73 | 2020-2021 | |
| Stryker Corporation | $24.17 | 2025 | Flowtriever |
| Novartis Pharmaceuticals Corporation | $21.52 | 2023 | |
| Paratek Pharmaceuticals, INC. | $17.87 | 2025 | Nuzyra |
| Mallinckrodt Enterprises LLC | $17.82 | 2019 | |
| Genentech USA, INC. | $17.79 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.38 | 2023 | Quviviq |
| Covidien LP | $17.17 | 2020 | |
| Horizon Therapeutics Plc | $17.02 | 2020 | |
| Csl Behring | $16.82 | 2019 | |
| Pfizer INC. | $15.85 | 2021 | |
| Hikma Pharmaceuticals USA | $15.79 | 2022 | |
| Covis Pharma Gmbh | $15.40 | 2022 | |
| Veran Medical Technologies, INC. | $15.32 | 2021 | |
| Circassia INC. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carmel Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.